GLA
WST icon

Great Lakes Advisors’s West Pharmaceutical WST Stock Holding History

Great Lakes Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-615
Closed -$203K – 904
2024
Q2 		$203K Sell
615
-14
-2% -$4.95K ﹤0.01% 810
2024
Q1 		$249K Buy
629
+7
+1% +$2.59K ﹤0.01% 733
2023
Q4 		$219K Sell
622
-25
-4% -$8.85K ﹤0.01% 732
2023
Q3 		$243K Sell
647
-9
-1% -$3.48K ﹤0.01% 693
2023
Q2 		$251K Sell
656
-3
-0.5% -$1.07K ﹤0.01% 681
2023
Q1 		$228K Buy
+659
New +$193K ﹤0.01% 751
2022
Q3 		– Sell
-856
Closed -$259K – 721
2022
Q2 		$259K Sell
856
-1,022
-54% -$333K 0.01% 599
2022
Q1 		$771K Buy
1,878
+970
+107% +$380K 0.01% 474
2021
Q4 		$426K Buy
908
+6
+0.7% +$2.58K 0.01% 539
2021
Q3 		$383K Buy
902
+26
+3% +$11K 0.01% 558
2021
Q2 		$315K Sell
876
-1
-0.1% -$330 ﹤0.01% 575
2021
Q1 		$247K Buy
877
+1
+0.1% +$286 ﹤0.01% 621
2020
Q4 		$248K Sell
876
-10
-1% -$2.81K ﹤0.01% 572
2020
Q3 		$244K Sell
886
-52,490
-98% -$13.9M 0.01% 515
2020
Q2 		$12.1M Buy
53,376
+3,452
+7% +$678K 0.29% 103
2020
Q1 		$7.6M Sell
49,924
-209
-0.4% -$32.2K 0.22% 118
2019
Q4 		$7.54M Sell
50,133
-33,913
-40% -$4.94M 0.16% 162
2019
Q3 		$11.9M Buy
84,046
+2,960
+4% +$408K 0.26% 98
2019
Q2 		$10.1M Buy
81,086
+2,031
+3% +$240K 0.22% 111
2019
Q1 		$8.71M Sell
79,055
-10,939
-12% -$1.14M 0.19% 126
2018
Q4 		$8.82M Buy
89,994
+14,024
+18% +$1.52M 0.21% 119
2018
Q3 		$9.38M Buy
75,970
+17,758
+31% +$1.99M 0.21% 110
2018
Q2 		$5.78M Sell
58,212
-85
-0.1% -$7.82K 0.14% 174
2018
Q1 		$5.15M Buy
58,297
+34,597
+146% +$3.24M 0.12% 174
2017
Q4 		$2.34M Buy
+23,700
New +$2.32M 0.05% 294

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Great Lakes Advisors's WST Position: Q3 2024 in Review

Great Lakes Advisors sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 615 shares — an estimated $203K sold.

Great Lakes Advisors first reported a position in WST in Q4 2017 and held it in 25 quarters. The position peaked at $12.1M in Q2 2020. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Great Lakes Advisors reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Great Lakes Advisors sold 615 West Pharmaceutical shares in Q3 2024, an estimated $203K.
  • Great Lakes Advisors first reported a position in West Pharmaceutical in Q4 2017 and held it in 25 quarters.
  • Great Lakes Advisors's West Pharmaceutical position peaked at $12.1M in Q2 2020.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Great Lakes Advisors's 13F filing for Q3 2024, filed 4 Nov 2024.